VolitionRX Ltd (NYSE MKT LLC:VNRX)

3.85
Delayed Data
As of Jul 02
 -0.05 / -1.28%
Today’s Change
1.45
Today|||52-Week Range
9.28
-1.28%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$69.0M

Company Description

VolitionRX Ltd. operates as a development stage life sciences company. It intends to discover and develop blood-based diagnostic tests for different types of cancer and other diseases. The company was founded on August 5, 2010 and is headquartered in Singapore.

Contact Information

VolitionRX Ltd.
1 Scotts Road
Singapore Central Singapore 228208
P:
Investor Relations:
(659) 230-1938

Employees

Shareholders

Individual stakeholders24.51%
Mutual fund holders--
Other institutional--

Top Executives

Cameron John ReynoldsPresident, Chief Executive Officer & Director
Mike O'ConnellChief Financial Officer & Treasurer
Jason Bradley TerrellChief Medical Officer & Head-US Operations
Jacob Vincent MicallefChief Scientific Officer
Thomas BygottDirector-Sales & Marketing

To view my watchlist

Not a member yet?

Sign up now for a free account